Failure to meet quality requirements for this batch was found regarding the microbiological purity parameter, which may indicate the presence of microorganisms in the product and a potential risk to patients' health. Potential effects: infections, adverse reactions, lack of treatment efficacy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch A1001119; if you have it, return it to a pharmacy or consult a doctor or pharmacist.
The Chief Pharmaceutical Inspector withdrew batch A1001119 of Megalia from the market throughout the country and granted the decision immediate enforceability; the marketing authorisation holder was o...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related